Page 108 - 南京医科大学自然版
P. 108

南京医科大学学报(自然科学版)                                  第44卷第7期
               ·992 ·                     Journal of Nanjing Medical University(Natural Sciences)   2024年7月


             ·综      述·

              基于基因测序技术分析乳腺癌中微生物菌群的研究进展



              王清华 ,李 溯 ,杨          蕊 ,陈道桢    1,3*
                     1
                             2
                                     1
               江南大学附属妇产医院优生优育遗传研究所,江苏                   无锡   214002;南京医科大学附属无锡妇幼保健院优生优育遗传研究
              1                                                     2
              所,江苏 无锡       214002;青海省海东市第二人民医院院长办公室,青海                海东 810600
                                  3

             [摘    要] 乳腺癌中存在独特的细菌群落,与正常乳腺组织、乳腺良性疾病以及癌旁组织在数量和多样性上均存在显著差
              异。乳腺癌不同分子分型、病理分级和分期之间的菌群结构也不同,这表明微生物菌群可能在乳腺癌的发生、发展及治疗中发
              挥重要的作用。然而,受种族和地域差异、样本量、测序深度等方面的影响,目前的研究结果存在差异,且缺乏系统性的综述。
              因此,文章通过总结乳腺癌微生物菌群测序的最新研究进展,系统分析了乳腺癌组织与非癌组织、乳腺癌不同分子分型、病理
              分级和分期之间微生物的组成差异,并对微生物菌群在乳腺癌诊断及治疗中的作用进行展望和讨论,以期为基于微生物菌群
              的乳腺癌诊断及治疗提供全新视角。
             [关键词] 微生物组;乳腺癌;基因测序技术

             [中图分类号] R737.9                    [文献标志码] A                      [文章编号] 1007⁃4368(2024)07⁃992⁃10
              doi:10.7655/NYDXBNSN230626



              Research progress on the analysis of microbial microbiota in breast cancer based on
              gene sequencing technology

                            1     2         1              1,3*
              WANG Qinghua ,LI Su ,YANG Rui ,CHEN Daozhen
                                                                                                  2
              1 Department of Eugenic Genetics Institute,Jiangnan University Maternity Hospital,Wuxi 214002;Department of
              Eugenic Genetics Institute,the Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical
              University,Wuxi 214002;Dean’s Office,The Second People’s Hospital of Haidong City,Haidong 810600,China
                                   3


             [Abstract] Breast cancer harbors a distinctive microbial community that significantly differs in quantity and diversity from normal
              breast tissue,benign breast diseases,and adjacent non⁃cancerous tissues. Moreover,the microbial composition varies among different
              molecular subtypes,grades,and stages of breast cancer. This suggests that the breast cancer⁃associated microbiota play an important
              role in the initiation,progression,and treatment of breast cancer. Nevertheless,due to factors such as ethnic and geographical
              disparities,sample sizes,and sequencing depths,there are discrepancies in current research results,and there is a lack of
              comprehensive reviews. Therefore,this paper summarizes the latest research progress on microbiota sequencing in breast cancer,
              systematically analyzes the differences in microbial composition between breast cancer tissues and non⁃cancerous tissues,and between
              different molecular subtypes,pathological grades and stages of breast cancer,and discusses the roles of microbiota in the diagnosis
              and treatment of breast cancer,with the aim of providing a new perspective for the future diagnosis and treatment of breast cancer
              based on microbiota.
             [Key words] microbiome;breast cancer;gene sequencing technology
                                                                           [J Nanjing Med Univ,2024,44(07):992⁃1001]





                  乳腺癌是威胁女性健康及生命的最常见恶性                           肿瘤,根据2020年全球癌症统计报告公布的结果,乳
                                                                腺癌已超过肺癌成为女性发病率和死亡率最高的癌
                                                                  [1]
                                                                                                         [2]
             [基金项目] 青海省自然科学基金计划(2022⁃ZJ⁃912)                    种 。乳腺癌的早期诊断有助于降低死亡率 ,因
              ∗                                                 此,开发新型乳腺癌诊断标记物及有效的治疗策略
              通信作者(Corresponding author),E⁃mail:chendaozhen@163.com
   103   104   105   106   107   108   109   110   111   112   113